Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - zafirlukast - oral tablet - 20mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - zafirlukast - oral tablet - 20mg

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

astrazeneca limited - zafirlukast 20mg;  ;   - tablet - 20 mg - active: zafirlukast 20mg     excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water   titanium dioxide

Stati Uniti - Ingliż - NLM (National Library of Medicine)

aurobindo pharma limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

par pharmaceutical inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - zafirlukast - oral tablet - 20mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - zafirlukast - oral tablet - 20mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - zafirlukast - oral tablet - 20mg